Metformin has direct effects on human ovarian steroidogenesis

被引:197
作者
Mansfield, R
Galea, R
Brincat, M
Hole, D
Mason, H
机构
[1] St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England
[2] Univ Malta, Sch Med, Dept Obstet & Gynaecol, Msida, Malta
[3] St George Hosp, Sch Med, Dept Obstet & Gynecol, London SW17 0RE, England
关键词
metformin; polycystic ovary syndrome; steroidogenesis;
D O I
10.1016/S0015-0282(02)04925-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the possibility of direct effects of metformin on ovarian steroidogenesis. Design: Cultured ovarian cells. Setting: Academic research environment. Patient(s): Women undergoing bilateral salpingoophorectomy for benign gynecological disease. Main Outcome Measure(s): Estradiol and P were measured in granulosa cell (GC) conditioned medium and androstenedione (A) and P in theca conditioned medium. Result(s): The effect of addition of metformin alone to GCs was variable, but significant inhibition of both P and E-2 was seen (range 0%-30%). Metformin dose-dependently inhibited gonadotrophin and insulin-stimulated P and E-2 production (range 25%-50%). In theca, metformin inhibited A production (0%-40%) with no effect on P. In the presence of insulin, A was inhibited dose-dependently and P increased by a similar magnitude. Conclusion(s): These results demonstrate a direct effect of metformin on ovarian steroidogenesis. The inhibitory effects on androgen production in particular would be beneficial in polycystic ovary syndrome (PCOS). (C) 2003 by American Society for Reproductive Medicine.
引用
收藏
页码:956 / 962
页数:7
相关论文
共 38 条
[1]   PROSTAGLANDIN-F2-ALPHA ACTIVATES PROTEIN-KINASE-C IN HUMAN OVARIAN-CELLS [J].
ABAYASEKARA, DRE ;
JONES, PM ;
PERSAUD, SJ ;
MICHAEL, AE ;
FLINT, APF .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1993, 91 (1-2) :51-57
[2]   Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase [J].
Arlt, W ;
Auchus, RJ ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :16767-16771
[3]   Metformin directly inhibits androgen production in human thecal cells [J].
Attia, GR ;
Rainey, WE ;
Carr, BR .
FERTILITY AND STERILITY, 2001, 76 (03) :517-524
[4]  
Campbell BK, 1998, J REPROD FERTIL, V112, P69, DOI 10.1530/jrf.0.1120069
[5]  
CHANG RJ, 1993, J CLIN ENDOCR METAB, V57, P356
[6]  
CLUECK CJ, 1999, METABOLISM CLIN EXPT, V48, P511
[7]   HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME - CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS [J].
CONWAY, GS ;
HONOUR, JW ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1989, 30 (04) :459-470
[8]   Polycystic ovary syndrome: Clinical aspects [J].
Conway, GS .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1996, 10 (02) :263-279
[9]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[10]   Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Schneider, DJ ;
Sobel, BE ;
Cavaghan, MK ;
Imperial, J ;
Rosenfield, RL ;
Polonsky, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116